Governance Greg Boss JD, BS (Hon) Age 62 Executive Vice President, Legal and CSL Group General Counsel Hervé Gisserot IEP Age 58 Senior Vice President and General Manager CSL Vifor Mark Hill BA (Organisational Management) Executive MBA (Information Technology Management) Age 63 Executive Vice President, Chief Digital Information Officer Greg was appointed Group General Counsel in 2009 and is responsible for worldwide legal operations, risk management and compliance for all CSL Group companies. He joined CSL in 2001, serving as General Counsel for what became the CSL Behring business. Prior to joining CSL, Greg was Vice President and Senior Counsel for CB Richard Ellis International, after spending 10 years in private legal practice focusing on corporate and securities law. Hervé Gisserot was appointed Senior Vice President and General Manager of CSL Vifor in March 2023. He is responsible for the global CSL Vifor Business unit strategy and operations, leading a team of approx. 2,000 professionals. Prior to being appointed to his current role, Hervé was Chief Commercial Officer and member of the Executive Committee of Vifor Pharma. Hervé brings extensive commercial experience gained in leadership roles at major healthcare companies around the world. Mark Hill is the Chief Digital Information Officer at CSL. He leads the enterprise-wide Digital Technology organisation and its accompanying strategy. Mark plays a key role in how CSL manages plasma donors, connects with patients, virtually collaborates and drives greater efficiencies in operations. He is a global IT leader with extensive experience in utilising enabling technology to deliver efficiency, productivity, quality and solutions for patients and public health. For more more information on CSL’s Global Leadership Group see our website CSL.com/we-are-csl/ourleadership#GLG Leadership team CSL’s Global Leadership Group is responsible for driving company performance so that it can keep CSL’s promises to our patients, our employees and our shareholders. They have earned their roles because of their experience, achievements, unwavering ethics and commitment to CSL’s core values. Paul McKenzie PhD (Chemical Engineering) Age 58 Chief Executive Officer and Managing Director Joy Linton BComm; F. Fin; GAICD Age 58 Chief Financial Officer Dr McKenzie was appointed Chief Executive Officer and Managing Director of CSL Limited on 6 March 2023. After joining CSL as Chief Operating Officer in 2019, Dr McKenzie became accountable for optimising CSL’s operations as well as growing the CSL Seqirus, CSL Plasma, and CSL Vifor businesses. Prior to joining CSL, Dr McKenzie was Executive Vice President of Pharmaceutical Operations & Technology at Biogen. He also served in a range of progressively senior level roles in R&D and manufacturing at Johnson & Johnson, Bristol-Myers Squibb and Merck. Joy Linton was appointed Chief Financial Officer in October 2020. Prior to joining CSL, Joy was chief financial officer and executive director at Bupa, a global health insurance company based in the UK, and earlier served as the General Manager of health services for Bupa UK. Joy has over 30 years’ experience in branded consumer businesses across insurance, healthcare and fast-moving consumer goods as a global and strategic chief financial officer. 62 Limited Annual Report 2023/24
RkJQdWJsaXNoZXIy MjE2NDg3